Exploring innovative treatments to prevent and cure infectious diseases
Each year, more than one million people around the globe die from infectious diseases. Our researchers are investigating revolutionary strategies and therapies to help prevent, manage and eradicate some of these major diseases worldwide.
We focus on both fundamental biology and clinical translation that will lead to new tools and novel treatments for arbovirus infections, viral cancers, COVID-19, genetic diseases, gut and oral health, urinary tract and respiratory infection.
Our impact
Project 1
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec sit amet ipsum dignissim, egestas nisl quis, pulvinar justo. Praesent dictum leo in elementum scelerisque. Nulla lorem mauris, ultrices a consectetur et, tristique quis augue.
Project 2
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec sit amet ipsum dignissim, egestas nisl quis, pulvinar justo. Praesent dictum leo in elementum scelerisque. Nulla lorem mauris, ultrices a consectetur et, tristique quis augue.
Project 3
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec sit amet ipsum dignissim, egestas nisl quis, pulvinar justo. Praesent dictum leo in elementum scelerisque. Nulla lorem mauris, ultrices a consectetur et, tristique quis augue.
Our mission
Our goal is to better understand and control infectious agents that cause significant death and disease worldwide.
Program Director
Professor McMillan
Professor McMillan is a renowned cancer researcher specialising in the infectious causes of cancer.
He is an internationally-recognised expert in the area of human papillomavirus, gene editing and gene silencing. He has over 90 publications and has had continuous NHRMC funding for more than 22 years.
Media
Cell and Gene Medicine
Our purpose
We bring together renowned researchers from across the University to investigate and develop new therapies for diseases such as cystic fibrosis, HIV, cancer and rare genetic diseases such as Mucopolysaccharidoses.
Key focus areas
- Infectious diseases
- Diseases of the liver
- Cystic Fibrosis and MPS1
- Delivery of therapies to the brain
Our impact
A team of international scientists have developed an experimental direct-acting antiviral to treat COVID-19.
Emerging Viruses, Inflammation and Therapeutics
Our purpose
Our goal is to develop new therapies for emerging and existing mosquito-borne viruses that cause debilitating disease worldwide.
Key focus areas
- Chikungunya virus
- Dengue fever
- Respiratory viruses
- Ross River virus
- Zika virus
Our impact
Professor Suresh Mahalingam discusses vaccine development for dengue fever and other mosquito-borne infectious diseases.
Infection and Immunity
Our purpose
Our work examines the process of infection and immune responses, with the goal of promoting human health and control of human disease.
Key focus areas
- Defining chronic infectious diseases
- Immunological responses
- Novel prevention and treatments
- Mechanisms of microbial disease and virulence
- Bridging the research needs of primary healthcare
Spatial biology research
Spatial biology research
The Griffith University Centre (CoE) of Excellence in Spatial Biology is the first of its kind in Australia and offers state-of-the-art immune profiling techniques across a range of diseases.
With a focus on mucosal and tissue immunology, the CoE provides innovative research in oncology, atopic and chronic inflammatory diseases and in data science and bioinformatics.
Latest news
Spinal Cord Injury rehabilitation technology steps toward commercialisation
12 Apr 2024
Griffith University’s BioSpine team, led by Dr Claudio Pizzolato, has won a coveted place in a...
Does your foot shape dictate how well you do the locomotion, baby?
30 Jan 2024
A Griffith University and UQ research collab is reshaping our understanding of human biomechanics.
Key muscle protein may unlock the mystery of chronic mosquito-borne viral...
27 Oct 2023
Underlying evolutionary dynamics could play a key role in the replication and progress of the...
Understanding drinking behaviours in young Australian adults
23 Oct 2023
Young Australian adults aged 18-24 years are more likely to binge drink than any other age group.
Contact details
- Phone
- (07) 5678 8811
- Location and postal address
- Menzies Health Institute Queensland
- G40 Griffith Health Centre, Level 8.86
- Gold Coast campus
- Griffith University QLD 4222
